Patents by Inventor Mark D. Lindrud

Mark D. Lindrud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Form of irbesartan, processes for obtaining the said and pharmaceutical compositions containing it
    Patent number: 7008959
    Abstract: The invention relates to a novel crystalline form of irbesartan to pharmaceutical compositions containing it, to processes for preparing it, and to a method for treating cardiovascular diseases utilizing it.
    Type: Grant
    Filed: September 9, 2004
    Date of Patent: March 7, 2006
    Assignee: Sanofi-Aventis
    Inventors: Bruno Franc, Christian Hoff, San Kiang, Mark D. Lindrud, Olivier Monnier, Chenkou Wei
  • Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
    Patent number: 6800761
    Abstract: The invention relates to a novel crystalline form of irbesartan, to pharmaceutical compositions containing it, to processes for preparing it, and to a method for treating cardiovascular diseases utilizing it.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: October 5, 2004
    Assignee: Sanofi-Synthelabo
    Inventors: Bruno Franc, Christian Hoff, San Kiang, Mark D. Lindrud, Olivier Monnier, Chenkou Wei
  • Sonic impinging jet crystallization apparatus and process
    Patent number: 6302958
    Abstract: A novel apparatus and process for crystallizing submicron-sized crystals of a pharmaceutical composition. The submicron-sized crystals, which have an average size of less than 1 micron, provide high surface area end product crystals with greatly improved stability and purity, and which afford crystals having improved bioavailability, higher dissolution, decreased decomposition rate and longer shelf-life.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: October 16, 2001
    Assignee: Bristol-Myers Squibb Company
    Inventors: Mark D. Lindrud, Soojin Kim, Chenkou Wei
  • Bisulfate salt of HIV protease inhibitor
    Patent number: 6087383
    Abstract: The present invention provides the crystalline bisulfate salt of the formula ##STR1## which is found to have unexpectedly high solubility/dissolution rate and oral bioavailability relative to the free base form of this azapeptide HIV protease inhibitor compound.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: July 11, 2000
    Assignee: Bristol-Myers Squibb Company
    Inventors: Janak Singh, Madhusudhan Pudipeddi, Mark D. Lindrud